Nóra Kucsma

Institute of Molecular Life Sciences — Hungary

Medicine · Health Sciences

16h-index612citations48works4.62yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug Transport and Resistance Mechanisms(30), Nanoparticle-Based Drug Delivery(6), Metal complexes synthesis and properties(6), Radiopharmaceutical Chemistry and Applications(6), Mass Spectrometry Techniques and Applications(5)

Publications48 total

Redox-dependent condensation and cytoplasmic granulation by human ssDNA-binding protein-1 delineate roles in oxidative stress response
iScience·2024· 4 citedOpen Access
Characterisation of Canine and Feline Breast Tumours, Their Metastases, and Corresponding Primary Cell Lines Using LA-REIMS and DESI-MS Imaging
International Journal of Molecular Sciences·2024· 6 citedOpen Access
Copper(II) Complexes with Isomeric Morpholine-Substituted 2-Formylpyridine Thiosemicarbazone Hybrids as Potential Anticancer Drugs Inhibiting Both Ribonucleotide Reductase and Tubulin Polymerization: The Morpholine Position Matters
Journal of Medicinal Chemistry·2024· 13 citedOpen Access
Redox-dependent phase separation and cytoplasmic granulation by human single-stranded DNA binding protein 1 (HSSB1) point to new mechanisms of cellular stress response
Biophysical Journal·2024Open Access
Redox-Dependent Condensation and Cytoplasmic Granulation by Human ssDNA Binding Protein 1 Delineate Roles in Oxidative Stress Response
SSRN Electronic Journal·2024Open Access
Redox-dependent condensation and cytoplasmic granulation by human ssDNA binding protein 1 delineate roles in oxidative stress response
2023· 1 citedOpen Access
Figure S4 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Figure S4 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Figure S2 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Supplementary Table 1 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Figure S2 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Figure S1 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Data from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Figure S1 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Supplementary Table 1 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Figure S3 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Data from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Figure S3 from Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
2023Open Access
Data from Unshielding Multidrug Resistant Cancer through Selective Iron Depletion of P-Glycoprotein–Expressing Cells
2023Open Access
Data from Unshielding Multidrug Resistant Cancer through Selective Iron Depletion of P-Glycoprotein–Expressing Cells
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Gergely Szakács(40), Szilárd Tóth(24), Veronika F.S. Pape(20), József Tóvári(20), Dóra Türk(19), György Várady(16), András Füredi(14), Kornélia Szebényi(14), László Cervenak(13), Melinda Gera(8), Beáta G. Vértessy(7), Norbert Szoboszlai(7), Mihály Cserepes(6), Anikó Gaál(6), Christina Streli(6), Katalin Kiss(5), J. Szabó(5), Pál Szabó(5), Balázs Sarkadi(5), Bálint Jezsó(5)